Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of [111In]ABY-025 for SPECT Imaging in Metastatic Breast Cancer
NCT01216033Phase 2Completed
- Start
- Oct 2010
- Primary completion
- Jul 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of 111In-ABY-025 in breast cancer. Started Oct 2010; status: completed.
02
Drugs
111In-ABY-025
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01216033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216033.